Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.8305
-0.0183 (-2.16%)
At close: Dec 5, 2025, 4:00 PM EST
0.8350
+0.0045 (0.54%)
After-hours: Dec 5, 2025, 7:51 PM EST
Purple Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
7.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PPBT News
- 2 days ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 22 days ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 6 weeks ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 3 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 3 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Purple Biotech Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025 - GlobeNewsWire